Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Titel:
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Auteur:
Padidela, Raja Whyte, Michael P. Glorieux, Francis H. Munns, Craig F. Ward, Leanne M. Nilsson, Ola Portale, Anthony A. Simmons, Jill H. Namba, Noriyuki Cheong, Hae Il Pitukcheewanont, Pisit Sochett, Etienne Högler, Wolfgang Muroya, Koji Tanaka, Hiroyuki Gottesman, Gary S. Biggin, Andrew Perwad, Farzana Williams, Angela Nixon, Annabel Sun, Wei Chen, Angel Skrinar, Alison Imel, Erik A.